Stay updated on Enfortumab Vedotin in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Enfortumab Vedotin in Solid Tumors Clinical Trial page.

Latest updates to the Enfortumab Vedotin in Solid Tumors Clinical Trial page
- ChecktodayChange DetectedAdded publication reference: Muro K et al. Phase II trial of enfortumab vedotin in patients with previously treated gastric and esophageal cancers, ESMO Open. 2025;10(11):105806 (doi:10.1016/j.esmoop.2025.105806). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check7 days agoNo Change Detected
- Check29 days agoChange Detected- Added a government funding operating-status notice and a new version tag v3.2.0. - Removed a specific resource reference: Genetic and Rare Diseases Information Center resources: Carcinoma of esophagus (with revision v3.1.0). If the resource was not core, this removal is minor; the new status notice is the primary change.SummaryDifference1%

- Check36 days agoChange DetectedPage revision updated from v3.0.2 to v3.1.0, indicating a version bump with no other substantive content changes.SummaryDifference0.0%

- Check43 days agoChange DetectedUpdated the study citation to reflect a different publication status: from “Epub 2025 Jul 9” to “Online ahead of print,” with the main bibliographic details otherwise unchanged.SummaryDifference0.1%

- Check50 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2 and the Back to Top element was removed; no substantive content changes.SummaryDifference0.1%

- Check57 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.SummaryDifference0.1%

Stay in the know with updates to Enfortumab Vedotin in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Enfortumab Vedotin in Solid Tumors Clinical Trial page.